Limousin W, Laurent-Puig P, Ziol M, Ganne-Carrie N, et al. Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab. J Hepatol 2023 Aug 28:S0168-8278(23)05070-5. doi: 10.1016/j.jhep.2023.
PMID: 37647991